Spironolactone vs Pantoprazole: side-by-side comparison
Spironolactone (Potassium-sparing diuretic / aldosterone antagonist) and Pantoprazole (Proton pump inhibitor) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Spironolactone | Pantoprazole |
|---|---|---|
| Therapeutic class | Potassium-sparing diuretic / aldosterone antagonist | Proton pump inhibitor |
| CAS | 52-01-7 | 102625-70-7 |
| ATC | C03DA01 | A02BC02 |
| Molecular weight | 416.57 g/mol | 383.37 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Spironolactone and Pantoprazole share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Spironolactone acts by a different mechanism than Pantoprazole, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Spironolactone: Spironolactone competitively blocks the mineralocorticoid (aldosterone) receptor in the distal tubule of the kidney, reducing sodium reabsorption and potassium excretion. Pantoprazole: Pantoprazole is a substituted benzimidazole prodrug activated in the acidic environment of the gastric parietal cell, where it irreversibly inhibits the H+/K+-ATPase enzyme — the proton pump responsible for the final ste…
Indications compared
Spironolactone: Spironolactone is approved for heart failure with reduced ejection fraction, primary hyperaldosteronism, resistant hypertension, oedema in cirrhosis or nephrotic syndrome, and certain potassium-loss states. Pantoprazole: Pantoprazole is approved in adults and children for the treatment of gastro-oesophageal reflux disease, including erosive oesophagitis healing and maintenance, peptic ulcer disease, prevention of NSAID-induced ulcers, Zo…
Safety profile
Spironolactone: Common adverse effects include hyperkalaemia (especially with renal impairment or ACE inhibitors), gynaecomastia in men, menstrual irregularities in women, and dizziness from blood pressure effects. Pantoprazole: Common adverse effects include headache, gastrointestinal symptoms and dizziness.
Frequently asked questions
Is Spironolactone better than Pantoprazole? ▾
Spironolactone and Pantoprazole are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Spironolactone and Pantoprazole be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Spironolactone
Products with Pantoprazole
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.